Tag Archives: cochrane database of systematic reviews

Home-based educational interventions for children with asthma.

CONCLUSIONS: We found inconsistent evidence for house-based asthma educational interventions compared to average attention, education delivered outside of the house or a less intensive educational intervention delivered at house. Although education remains a key component of managing asthma in children, advocated in numerous guidelines, this review does not contribute further data on the fundamental content and optimum setting for such educational interventions.
PMID: 21975783 [PubMed - in action] (Source: Cochrane Database of Systematic Reviews) More information: More info...

Tags: PMID, cochrane database of systematic reviews, action, Health, house, fundamental content…

Read full storyComments { 0 }

Interventions for dealing with dental lichen planus.

Authors: Thongprasom K, Carrozzo M, Furness S, Lodi G

Dental lichen planus (OLP) is a very common chronic autoimmune disease connected with cell-mediated immunological disorder. Symptomatic OLP is painful and finish healing is rare.

PMID: 21735381 [PubMed - in action] (Source: Cochrane Database of Systematic Reviews) More details: Mornfo...

Tags: interventions, lodi, cochrane database of systematic reviews, oral lichen planus, Health…

Read full storyComments { 0 }

Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.

Authors: Ducharme FM, Lasserson TJ, Cates CJ
Asthma patients who carry on to familiarity signs and symptoms despite being on regular inhaled corticosteroids (ICS) represent a management challenge. Extended-acting beta(2)-agonists (LABA) or anti-leukotrienes (LTRA) are two therapy options that could be considered as add-on therapy to ICS.
PMID: 21563136 [PubMed - in action] (Supply: Cochrane Database of Systematic Reviews) More information: Read more...

Tags: ltra, action, Authors, beta 2 agonists, cochrane database of systematic reviews, Health…

Read full storyComments { 0 }

Intravenous immunoglobulins for epilepsy.

Authors: Geng J, Dong J, Li Y, Ni H, Jiang K, Shi LL, Wang G
Epilepsy is a common neurological condition, with an estimated incidence of 50 per 100,000 persons. Human beings with epilepsy may present with various types of immunological abnormalities, such as low serum IgA level, lack of IgG subclass and identification of certain types of antibodies. Intravenous immunoglobulin (IVIg) treatment may represent a valuable approach and its efficacy has vital implications for epilepsy management.
PMID: 21249713 [PubMed - in action] (Source: Cochrane Database of Systematic Reviews) More information: Read more...

Tags: cochrane database of systematic reviews…

Read full storyComments { 0 }